Arvelle Therapeutics - Angelini Pharma Company
Edit

Arvelle Therapeutics - Angelini Pharma Company

https://www.arvelletx.com/
Last activity: 07.07.2022
Categories: BioTechDevelopmentDrugHardwareHealthTechInformationLearnMarketMedtechWebsite
We are a Swiss-based biopharmaceutical company focused on bringing innovative treatments to patients suffering from CNS disorders. Part of Angelini Pharma.
Followers
5.59K
Mentions
11
Location: Switzerland, Zug
Employees: 51-200
Valuation: $960M
Founded date: 2019

Investors 7

Mentions in press and media 11

DateTitleDescriptionSource
07.07.2022No­vo Nordisk work­ers in Ko­rea protest af­ter break­down i...With a team of Axovant veterans leading the way, CNS startup Arvelle Therapeutics is nearing approva...endpts.com...
05.01.2021Andera sells its Life Sciences’ portfolio company Arvelle Th...anderapart...
04.01.2021Arvelle Therapeutics exits at a valuation of $960 millionstartuptic...
04.01.2021Arvelle Therapeutics exits at a valuation of $960 millionArvelle Therapeutics is responsible for developing and commercialising cenobamate in the European ma...startuptic...
14.09.2020Arvelles Präparat darf in Deutschland für Härtefälle verwend...Mit der Entscheidung des Bundesinstituts erreicht das biopharmazeutische Startup, das sich auf die E...startuptic...
14.09.2020Arvelles Präparat darf in Deutschland für Härtefälle verwend...startuptic...
20.08.2020First patients to soon benefit from Arvelle Therapeutics’ th...Arvelle Therapeutics is an emerging biopharmaceutical company responsible for the development and co...startuptic...
20.08.2020First patients to soon benefit from Arvelle Therapeutics’ th...startuptic...
03.04.2020Arvelle Therapeutics’ antiepileptic drug is a step closer to...Arvelle Therapeutics, an emerging biopharmaceutical company, is focused on bringing innovative treat...startuptic...
03.04.2020Arvelle Therapeutics’ antiepileptic drug is a step closer to...startuptic...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In